Toxicity of Immunotherapies in Melanoma

Special ReportsMelanoma (Issue 4)
Volume 4
Issue 1

Jeffrey S. Weber, MD, PhD, a senior member at Moffitt Cancer Center, discusses toxicities associated with immunotherapies for the treatment of patients with melanoma.

Jeffrey S. Weber, MD, PhD, a senior member at Moffitt Cancer Center, discusses toxicities associated with immunotherapies for the treatment of patients with melanoma.

<<<

Back to the Melanoma Special Report

Related Videos
Expert on melanoma
Expert on melanoma
Expert on melanoma